| Medicinal product name | Voriconazole Teva 200 mg film-coated tablets |
|---|---|
| Pharmaceutical form | Film-coated tablet |
| Strength | 200 mg |
| Information from the MAH on shortages |
Not available predicted availability date: Jun 30, 2024 |
| Legal status | Prescription (Pr.) |
| Summary of product characteristics |  23-01-2024
|
| Package leaflet | 25-07-2023
|
| Risk minimisation measures | Izglītojošie materiāli ārstam Izglītojošie materiāli pacientam |
| ATC code | J02AC03 – Antimycotics for systemic use |
| Information for Marketing authorisation holders | View |
Medicinal products (20)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N2 (200 mg) |
PVC/Al blister | 13-0171-04 |
 Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10 (200 mg) |
PVC/Al blister | 13-0171-05 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14 (200 mg) |
PVC/Al blister | 13-0171-06 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20 (200 mg) |
PVC/Al blister | 13-0171-07 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N28 (200 mg) |
PVC/Al blister | 13-0171-08 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (200 mg) |
PVC/Al blister | 13-0171-09 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50 (200 mg) |
PVC/Al blister | 13-0171-10 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56 (200 mg) |
PVC/Al blister | 13-0171-11 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N98 (200 mg) |
PVC/Al blister | 13-0171-12 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (200 mg) |
PVC/Al blister | 13-0171-13 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N2: 2 × 1 (200 mg) |
PVC/Al unit-dose blister | 13-0171-14 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N10: 10 × 1 (200 mg) |
PVC/Al unit-dose blister | 13-0171-15 |
Labelling text Jan 7, 2021 |
|
|
Not available (according to the information provided by wholesalers) predicted availability date: Jun 30, 2024 |
currently no information on availability from any wholesaler |
N14: 14 × 1 (200 mg) |
PVC/Al unit-dose blister | € 348.79 | 13-0171-16 |
Labelling text Jan 7, 2021 |
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N20: 20 × 1 (200 mg) |
PVC/Al unit-dose blister | 13-0171-17 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N28: 28 × 1 (200 mg) |
PVC/Al unit-dose blister | 13-0171-18 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30: 30 × 1 (200 mg) |
PVC/Al unit-dose blister | 13-0171-19 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N50: 50 × 1 (200 mg) |
PVC/Al unit-dose blister | 13-0171-20 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56: 56 × 1 (200 mg) |
PVC/Al unit-dose blister | 13-0171-21 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N98: 98 × 1 (200 mg) |
PVC/Al unit-dose blister | 13-0171-22 |
Labelling text Jan 7, 2021 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100: 100 × 1 (200 mg) |
PVC/Al unit-dose blister | 13-0171-23 |
Labelling text Jan 7, 2021 |
Registration information
| Marketing authorisation No. | 13-0171 |
|---|---|
| Date of authorisation | Aug 15, 2013 |
| Marketing authorisation holder, country | Teva Pharma B.V., Netherlands |
